Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Human Antibody-enabled Cardiovascular Personalized Theranosis

Project description

Advanced imaging techniques for atherosclerosis diagnosis

Atherosclerosis, a leading cause of heart disease, poses a challenge due to its complex and often asymptomatic progression. In this context, the EIC-funded ABCardionostics project will develop a multi-marker PET/MRI system. Specifically, ABCardionostics aims to enhance the staging and personalised treatment of patients with vulnerable atherosclerosis. The project focuses on creating human antibodies (HuAbs) that target specific monocyte/macrophage populations involved in plaque development. These antibodies will provide detailed insights into plaque composition and progression. Using advanced biotechnologies, including phage display and multispectral mapping, ABCardionostics will pioneer in vivo imaging techniques and novel immunotherapy strategies, potentially transforming diagnostic and therapeutic practices for atherosclerosis and beyond.

Objective

ABCardionostics envisions an innovative multi-marker-based positron emission tomography (PET)/ magnetic resonance imaging (MRI) system for efficient staging and personalized treatment of vulnerable patients with atherosclerosis. To provide a snapshot of plaque composition, along the arterial tree of at-risk patients, human antibodies (HuAbs) targeting different affected arterial sites will be developed. Importantly, HuAbs targeting culprit and protective monocyte/macrophage (MoMP) populations that are instrumental in plaque progression will be crucial to assess disease status and reprogramme an unbalanced functional state toward atheroprotection. To translate this concept into clinical practice, the ABCardionostics consortium will combine cutting-edge biotechnologies and in silico and computing analyses to close the knowledge gaps on plaque MoMP spatiotemporal dynamics and the lack of imaging approaches for multi-marker detection: pioneering in vivo and in vitro phage display approaches to identify relevant HuAbs (UBx), multispectral mapping and MacroScreen to unravel the functionomics of MoMP subsets in atherosclerosis (MUNC), unvisited in silico and biochip development to identify HuAb targets (MAbS, CNRS-TBI), innovative HuAb bioengineering techniques (CNRS-BacFly, and UBx-INP, BTM), derivatization and labelling to develop PET tracers to finally explore the feasibility of a translational non-invasive multi-marker PET/MRI system for diagnosis and monitoring (CNIC) and an adapted immunotherapy strategy targeted to the appropriate plaque by designing bispecific antibodies (CNRS-BacFly). Data processing will integrate multimodal images to obtain insight into plaque morphology and composition (PMI). ABCardionostics successful completion will bring HuAb leads for atherosclerosis theranosis, and novel tools for HuAb identification and design, easily transposable to other diseases, revolutionizing the current imaging and therapeutic approaches.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-EIC - HORIZON EIC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-EIC-2023-PATHFINDEROPEN-01

See all projects funded under this call

Coordinator

UNIVERSITE DE BORDEAUX
Net EU contribution
€ 903 041,25
Address
PLACE PEY BERLAND 35
33000 Bordeaux
France
Region
Nouvelle-Aquitaine Aquitaine Gironde
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 903 041,25

Participants (7)